Using Surveillance Data to Evaluate the Impact of Pneumococcal Conjugate Vaccine: Opportunities and Pitfalls

Ruth Link-Gelles, MPH, Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA